VivoSim Labs, Inc. (VIVS)
NASDAQ: VIVS · Real-Time Price · USD
0.8100
-0.0939 (-10.39%)
Jul 8, 2026, 11:12 AM EDT - Market open
VivoSim Labs Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 4.29 | 11.31 | 2.9 | 15.3 | 28.68 | 37.36 |
Short-Term Investments | - | - | - | 0.71 | - | - |
Cash & Short-Term Investments | 4.29 | 11.31 | 2.9 | 16.01 | 28.68 | 37.36 |
Cash Growth | 269.34% | 289.94% | -81.88% | -44.18% | -23.25% | 36.58% |
Accounts Receivable | 0.03 | 0.03 | 0.03 | 0.15 | - | - |
Other Receivables | 1.01 | - | - | - | - | - |
Total Trade Receivables | 1.04 | 0.03 | 0.03 | 0.15 | - | - |
Inventory | - | - | 0.3 | - | - | - |
Other Current Assets | 0.71 | 0.79 | 0.71 | 0.89 | 0.86 | 1.03 |
Total Current Assets | 6.04 | 12.13 | 3.94 | 17.05 | 29.53 | 38.4 |
Net Property, Plant & Equipment | 0.77 | 1.29 | 1.97 | 2.61 | 2.82 | 0.38 |
Other Long-Term Assets | 0.15 | 1.23 | 0.45 | 0.66 | 0.95 | 1.14 |
Total Assets | 6.96 | 14.65 | 6.35 | 20.31 | 33.3 | 39.92 |
Accounts Payable | 0.67 | 1.64 | 0.63 | 0.33 | 0.42 | 0.28 |
Accrued Expenses | 0.82 | 1.23 | 0.73 | 2.85 | 0.49 | 0.44 |
Short-Term Debt | 0.24 | 0.13 | - | - | - | - |
Current Portion of Leases | 0.53 | 0.52 | 0.51 | 0.49 | 0.48 | - |
Other Current Liabilities | 0.22 | 0.22 | - | - | - | - |
Total Current Liabilities | 2.48 | 3.74 | 1.86 | 3.67 | 1.38 | 0.72 |
Long-Term Leases | 0.04 | 0.42 | 0.89 | 1.31 | 1.7 | - |
Total Long-Term Liabilities | 0.04 | 0.42 | 0.89 | 1.31 | 1.7 | - |
Total Liabilities | 2.52 | 4.16 | 2.75 | 4.98 | 3.09 | 0.72 |
Common Stock | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 |
Treasury Stock | - | -0 | -0 | -0 | -0 | -0 |
Additional Paid-in Capital | 354.67 | 352.65 | 343.27 | 340.32 | 337.94 | 335.48 |
Accumulated Other Comprehensive Income | - | - | - | 0 | - | - |
Retained Earnings | -350.24 | -342.16 | -339.67 | -325 | -307.74 | -296.29 |
Shareholders' Equity | 4.44 | 10.49 | 3.6 | 15.33 | 30.21 | 39.2 |
Total Liabilities & Equity | 6.96 | 14.65 | 6.35 | 20.31 | 33.3 | 39.92 |
Total Debt | 0.81 | 1.07 | 1.39 | 1.81 | 2.18 | 0 |
Net Cash (Debt) | 3.48 | 10.24 | 1.51 | 14.2 | 26.49 | 37.36 |
Net Cash Growth | -66.06% | 579.63% | -89.39% | -46.39% | -29.10% | 36.58% |
Net Cash Per Share | 1.49 | 7.00 | 1.98 | 19.56 | 36.53 | 64.96 |
Book Value | 4.44 | 10.49 | 3.6 | 15.33 | 30.21 | 39.2 |
Book Value Per Share | 1.90 | 7.17 | 4.73 | 21.11 | 41.65 | 68.15 |
Tangible Book Value | 4.44 | 10.49 | 3.6 | 15.33 | 30.21 | 39.2 |
Tangible Book Value Per Share | 1.90 | 7.17 | 4.73 | 21.11 | 41.65 | 68.15 |